Top 20 Vaccines of 2024

Shots:Vaccines play an instrumental role in curbing infectious diseases by generating antibodies against antigens and creating a memory to defeat them. Several biopharma companies are steadfastly working to deliver vaccines against infectious and vaccine-preventable diseases around the worldIn 2024, the global vaccine market is estimated to be around $78B and is expected to…

ByPrince GiriJuly 11, 2024

TOP 20

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Shots: Sticking to M&A and licensing agreements can be really challenging, especially when dealing with stringent antitrust laws and evolving regulatory challenges. In such adverse scenarios, the rational and right step seems to be nullifying the existing deals.In 2023, the termination of the deal between Janssen and Arrowhead remained the talk of the town…

ByPrince GiriApril 18, 2024

TOP 20

Top 20 IPOs in Healthcare by Total Fund Value 2023

Shots:Clinical-stage biopharma companies are in constant need of funding and the best way to pull in money in such dire situations is by going public. 2023 had been a great year for Wall Streets across the globe with continuous announcements of IPOsKenvue by bagging $4.37B upon completion of its IPO ranked first in…

ByPrince GiriMarch 28, 2024

INSIGHTS+

Know Your Investor (March Edition): Qiming Venture Partners

Shots:In this reprise, we feature Qiming Venture Partners again, based on the investments in 2023. With more than 600 investments to date, Qiming boasts a strong portfolio of companies involved in Technology & Consumer and HealthcareIn 2023, Qiming closed 38 funding rounds comprising 11 in the first quarter, 10 in the second, 11…

BySenior EditorMarch 26, 2024

INSIGHTS+

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Shots:The EMA approved 5 BLA and 8 New Chemical Entities in February 2024, leading to treatments for patients and advances in the healthcare industryIn February 2024, the major highlighted drugs were Reblozyl to treat Transfusion-Dependent Anemia and Velsipity for the treatment of Severely Active Ulcerative ColitisPharmaShots has compiled a list of a total…

BySenior EditorMarch 20, 2024

INSIGHTS+

Know Your Investor (February Edition): F-Prime Capital Partners

Shots: Know Your Investor is an earnest effort from PharmaShots to acquaint our readers with leading Investors and venture capital firms in the healthcare industry Founded in 1969, F-Prime Capital Partners is a subsidiary of Fidelity Investments and primarily invests in healthcare and technology A total of 40 investments were closed by F-Prime in 2023,…

BySenior EditorFebruary 27, 2024

SPOTLIGHT

Spotlight Interview: David Esposito CEO at ONL Therapeutics in a Stimulating Conversation with PharmaShots

“Spotlight-Company of the Month” offers a unique platform for biopharma, life sciences, and healthcare companies, allowing them to connect with their target audiences and like-minded people. This month at PharmaShots’ Spotlight, we had an opportunity to engage in conversation with David Esposito CEO at ONL Therapeutics. David discusses the company's lead candidate ONL1204, which is…

ByHimanshu SehgalFebruary 19, 2024

THOUGHTSPOT

6 Widely Used Content Marketing Formats by Biopharma Companies

Shots: Have you ever wondered what content formats leading biopharma companies have been using that receive wonderful responses and wholesome reviews? With PharmaShots, let’s navigate the trending content formats that biopharma companies have been exceedingly using In the data-driven world regulated by social media, it is necessary to have a strong media presence. For companies…

BySaurabh ChaubeyFebruary 14, 2024

INSIGHTS+

Know Your Investor (January Edition): RA Capital Management LLC  

Shots:  New Year, New Us! Our hand-curated “Know Your Investor” reports will now be exploring leading investors of 2023  Founded in 2002, RA Capital forged ahead to become a key investor in life science and healthcare companies. In 2023, RA Capital closed 40 major investments in biopharma companies, devices, manufacturing, service offering firms, and diagnostics  …

BySenior EditorJanuary 31, 2024

EVENTS

Free Webinar: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

“If you know the enemy and Know Yourself, you need not fear the results of a hundred battles” - Sun Tzu (Art of War) The quote above from The Art of War by Sun Tzu delves into the essence of our upcoming webinar. Embark on a journey of learning with PharmaShots! An exclusive webinar dedicatedly designed…

BySenior EditorSeptember 4, 2023

Top 20 Vaccines of 2024

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Top 20 IPOs in Healthcare by Total Fund Value 2023

Know Your Investor (March Edition): Qiming Venture Partners

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Know Your Investor (February Edition): F-Prime Capital Partners

Spotlight Interview: David Esposito CEO at ONL Therapeutics in a Stimulating Conversation with PharmaShots

Know Your Investor (January Edition): RA Capital Management LLC

Free Webinar: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter